ClinicalTrials.gov
ClinicalTrials.gov Menu

A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01146990
Recruitment Status : Recruiting
First Posted : June 22, 2010
Last Update Posted : April 10, 2018
Sponsor:
Collaborator:
Registrat-Mapi
Information provided by (Responsible Party):
AMAG Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2020
  Estimated Study Completion Date : October 2020